Shih-Wei Lin

Title: **Shih-Wei Lin: Innovator in Tobacco Addiction Reduction**

Introduction

Shih-Wei Lin is an innovative inventor based in Taiwan, recognized for his contributions to methods that address tobacco addiction. With a background in biotechnology, he has focused on developing solutions that can assist smokers in overcoming their addiction to nicotine.

Latest Patents

Shih-Wei Lin holds a patent for a groundbreaking method aimed at reducing tobacco addiction in smoking subjects using Lactobacillus fermentum GKF3. This patented method involves the daily administration of an oral composition containing GKF3, which significantly reduces the total amount of nicotine metabolites excreted in urine. This innovation has the potential to impact many individuals struggling with tobacco dependence.

Career Highlights

Shih-Wei Lin is affiliated with Grape King Bio Ltd, a company dedicated to research and development in biotechnology and health products. His work at Grape King Bio Ltd showcases his commitment to applying scientific research to tackle pressing health issues, specifically in the realm of addiction treatment.

Collaborations

Throughout his career, Shih-Wei Lin has collaborated with talented colleagues including Chin-Chu Chen and Yen-Lien Chen. Together, they work on innovative projects that align with the company's mission to enhance public health through impactful inventions.

Conclusion

Shih-Wei Lin's contributions to the field of addiction treatment underscore the importance of innovation in promoting health and well-being. His unique approach to combating tobacco addiction not only highlights his inventive capabilities but also establishes a pathway for further research and development in this crucial area.